NANOG and neoplasm: Intriguingly, following NK cell killing, the CD133 level of surviving tumor cells was dramatically increased from 20% to 80%, accompanied by upregulation of SOX2, OCT4, and NANOG stem cell marker expression (Fig. 1B–D).